Foundation Medicine (FMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 16,448 | 14,496 | 11,455 | 9,662 | 8,208 |
| Cost of Goods | 7,502 | 6,619 | 5,291 | 4,204 | 2,858 |
| Gross Profit | 8,946 | 7,877 | 6,164 | 5,458 | 5,350 |
| Operating Expenses | 22,426 | 22,259 | 18,596 | 19,152 | 17,332 |
| Operating Income | -12,978 | -13,763 | -12,141 | -13,490 | -11,124 |
| Interest Expense | 10 | 18 | 29 | 33 | 61 |
| Other Income | 8 | 2 | 4 | 432 | -1,278 |
| Pre-tax Income | -12,980 | -13,779 | -12,166 | -13,091 | -12,463 |
| Net Income Continuous | -12,980 | -13,779 | -12,166 | -13,091 | -12,463 |
| Net Income | $-12,980 | $-13,779 | $-12,166 | $-13,091 | $-12,463 |
| EPS Basic Total Ops | -0.46 | -0.49 | -0.44 | 4.77 | -3.51 |
| EPS Basic Continuous Ops | -0.46 | -0.49 | -0.44 | 4.74 | -3.50 |
| EPS Diluted Total Ops | -0.46 | -0.49 | -0.44 | 4.77 | -3.51 |
| EPS Diluted Continuous Ops | -0.46 | -0.49 | -0.44 | 4.74 | -3.50 |
| EBITDA(a) | $-10,860 | $-11,675 | $-10,226 | $-11,643 | $-10,038 |